Genomic Vision 

0
0
+€0,00+0% 00:00 Hoy

Estadísticas

Máximo del día
-
Mínimo del día
-
Máximo 52S
-
Mínimo 52S
-
Volumen
-
Volumen prom.
-
Cap. bursátil
0
Relación P/E
-
Rendimiento por dividendo
-
Dividendo
-

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.

Acerca de

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Mostrar más
CEO
Mr. Aaron Bensimon
Empleados
27
País
Francia
ISIN
FR0011799907
WKN
000A110TM

Cotizaciones

0 comentarios

Comparte tus ideas

Preguntas frecuentes

¿Cuál es el símbolo de la acción de Genomic Vision?▼
Según la bolsa, el símbolo de la acción puede variar. Por ejemplo, en la bolsa Boerse Muenchen, las acciones de Genomic Vision se negocian bajo el símbolo G09.MU.
¿Cuántos empleados tiene Genomic Vision?▼
A fecha de 1 de noviembre de 2026, la empresa cuenta con 27 empleados.
¿En qué sector se encuentra Genomic Vision?▼
Genomic Vision opera en el sector Salud y Bienestar.
¿Cuándo realizó Genomic Vision un split de acciones?▼
Genomic Vision no ha tenido ningún split reciente.
¿Dónde tiene su sede Genomic Vision?▼
La sede de Genomic Vision se encuentra en Bagneux, Francia.